Australia markets closed

ABBV Jan 2024 140.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
16.760.00 (0.00%)
As of 01:52PM EDT. Market open.
Full screen
Loading interactive chart…
  • PR Newswire

    Experience the JUVÉDERM® Difference with Allergan Aesthetics

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers to experience the JUVÉDERM® difference. The JUVÉDERM® Collection of Fillers is the number one selling collection of dermal fillers on the market and offers the largest portfolio of fillers specifically designed for different areas of the face to address key patient concerns, enabling a customized treatment approach.1 Injectable dermal fillers are highly sought-after treatments among consumers who are looking to address key si

  • Zacks

    Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA

    Roche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma in adults has been accepted in the United States.

  • Zacks

    AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

    Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.